Market revenue in 2023 | USD 2.9 million |
Market revenue in 2030 | USD 18.2 million |
Growth rate | 30.2% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Therapeutics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Therapeutics, Diagnostics |
Key market players worldwide | Novartis AG ADR, Oncopeptides AB, Bicycle Therapeutics PLC ADR, AstraZeneca PLC, Theratechnologies Inc, Cybrexa Therapeutics, AngioChem, Soricimed |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide drug conjugates market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 79.31% in 2023. Horizon Databook has segmented the South Africa peptide drug conjugates market based on therapeutics, diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
The peptide drug conjugate market in South Africa presents a dynamic competitive landscape with both opportunities and challenges. The market is witnessing growth propelled by increasing demand for targeted therapies and advancements in drug delivery technologies.
Domestic pharmaceutical companies and international players are vying for a foothold, fostering competition and driving innovation. Regulatory reforms and partnerships with academic institutions are further enhancing R&D capabilities.
However, pricing pressure, reimbursement complexities, and healthcare infrastructure disparities pose hurdles. Successful market penetration will likely require strategic collaborations, localized clinical trials, and a focus on affordability to cater to the diverse socio-economic spectrum.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa peptide drug conjugates market , including forecasts for subscribers. This country databook contains high-level insights into South Africa peptide drug conjugates market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account